1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Hyperlipidaemia: new trials by email Literature Review of Hyperlipidaemia trials Research Report on Hyperlipidaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT icosapent ethyl (IPE), Standard LDL-C-Lowering Therapy - Coronary Artery Disease, Hyperlipidaemia | Phase 4 | Not yet recruiting | China National Center for Cardiovascular Diseases | 100 | 2026-08-01 | 2026-08-13 |
Coronary Artery Disease (1) · Hyperlipidemias (1) · Hypertriglyceridemia (1)
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Dyslipidemias (1) · Heart Diseases (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1) · Myocardial Ischemia (1) · Nutritional and Metabolic Diseases (1) · Vascular Diseases (1)
eicosapentaenoic acid ethyl ester (1)
China National Center for Cardiovascular Diseases (1)
China (1)